Suraksha Diagnostic Ltd
Suraksha Diagnostic Ltd (SURAKSHA) last traded at ₹316, a market capitalisation of ₹1,644 crore, on a P/E of 45.9. Over the past 52 weeks the stock has ranged between ₹224 and ₹334. Suraksha Diagnostic Ltd last reported results for the quarter ended Jun 2026, with sales of ₹88 crore and net profit of ₹13 crore. Suraksha Diagnostic Ltd’s annual general meeting is scheduled for 22 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Suraksha Diagnostic Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Suraksha Diagnostic Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹88 cr, up 20.5% from ₹73 cr a year earlier. Net profit was ₹13 cr, up 44.4% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 67 | 60 | 65 | 73 | 79 | 78 | 81 | 88 |
| Expenses | 44 | 41 | 46 | 49 | 55 | 55 | 57 | 57 |
| Operating profit | 23 | 18 | 19 | 24 | 24 | 23 | 24 | 30 |
| OPM % | 35% | 31% | 29% | 33% | 31% | 30% | 30% | 35% |
| Other income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 |
| Depreciation | 9 | 9 | 9 | 9 | 10 | 11 | 11 | 11 |
| Profit before tax | 14 | 8 | 9 | 12 | 12 | 10 | 10 | 17 |
| Tax % | 26% | 26% | 22% | 26% | 27% | 28% | 38% | 22% |
| Net profit | 10 | 6 | 7 | 9 | 9 | 7 | 6 | 13 |
| EPS (₹) | 2.40 | 1.18 | 1.42 | 1.80 | 1.73 | 1.44 | 1.21 | 2.50 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Suraksha Diagnostic Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 140 | 223 | 190 | 219 | 252 | 310 | 325 |
| Operating profit | 25 | 49 | 47 | 73 | 82 | 95 | 102 |
| OPM % | 18% | 22% | 25% | 33% | 33% | 31% | 31% |
| Net profit | 6 | 24 | 6 | 23 | 31 | 31 | 35 |
| EPS (₹) | 93.33 | 344.20 | 94.49 | 342.46 | 6.11 | 6.18 | 6.88 |
TTM is the trailing twelve months to the most recent quarter.
Suraksha Diagnostic Ltd growth and returns
- 10 Years
- %
- 5 Years
- 17%
- 3 Years
- 18%
- TTM
- 23%
- 10 Years
- %
- 5 Years
- 32%
- 3 Years
- 61%
- TTM
- 8%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 4%
- 10 Years
- %
- 5 Years
- 14%
- 3 Years
- 15%
- Last Year
- 14%
Suraksha Diagnostic Ltd shareholding pattern
Promoters held 49.10% at Jun 2026, broadly unchanged since Jun 2025. FIIs 13.47% and DIIs 23.22%.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Promoters | 48.78% | 48.78% | 48.89% | 48.98% | 49.00% | 49.10% | 49.10% |
| FIIs | 15.39% | 14.46% | 13.95% | 13.73% | 13.46% | 13.46% | 13.47% |
| DIIs | 20.43% | 22.05% | 22.37% | 21.98% | 22.57% | 23.14% | 23.22% |
| Public | 15.39% | 14.71% | 14.79% | 15.30% | 14.98% | 14.31% | 14.20% |
| No. of shareholders | 98,662 | 87,275 | 79,670 | 75,304 | 70,963 | 67,107 | 64,866 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Suraksha Diagnostic Ltd’s AGM?
Suraksha Diagnostic Ltd’s annual general meeting is scheduled for 22 Sept 2026.
- AGM21st Annual General Meeting of the Company for FY 2025-26
See the full results calendar for every Indian company reporting in the next 30 days.
Suraksha Diagnostic Ltd corporate filings
- Newspaper Publication for Notice of the 21st Annual General Meeting(AGM) of the CompanyCompany Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Limited has issued a formal notice for its 21st Annual General…
Read the full analysis - Newspaper Publication for Notice of the 21st Annual General Meeting (AGM) of the CompanyCompany Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Limited has issued a formal notice for its 21st Annual General…
Read the full analysis - The text Transcript of Earning call held on 13 August 2026 at 11:30 a.m. (IST)with respect to the unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter ....Company Updatehigh impact
Cruxal's analysis: Suraksha Diagnostic Limited reported a robust start to FY27, with Q1 revenue reaching INR…
Read the full analysis - Intimation of outcome of audio recording of analyst/Institutional Investor/Organizations meet-"Earning Call" which was held today i.e. 13 August 2026Company Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Ltd has filed the intimation regarding the availability of the audio…
Read the full analysis - Intimation of outcome of audio recording of Analyst/Institutional Investor/ Organizations meet-"Earning call" held today i.e. 13 Auust 2026Company Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Ltd has filed the audio recording of its analyst and institutional…
Read the full analysis - Newspaper Publication of unaudited ( Standalone & Consolidated) Financial Results of the Company for the quarter ended 30 June 2026.Company Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Limited has formally published its unaudited standalone and…
Read the full analysis - Investor Presentation for quarter 1 ended 30 June 2026Company Updatehigh impact
Cruxal's analysis: Suraksha Diagnostic Limited delivered a robust Q1 FY27, reporting revenue from operations…
Read the full analysis - Press release in respect of unaudited ( Standalone and Consolidated) Financial Results for the quarter ended 30 June 2026Company Updatehigh impact
Cruxal's analysis: Suraksha Diagnostic Limited delivered a robust performance for the quarter ended 30 June…
Read the full analysis - Revised Record date if 15 September 2026 has been fixedCorp. Actionlow impact
Cruxal's analysis: Suraksha Diagnostic Ltd has announced a revision to its record date, now fixed for 15…
Read the full analysis - Outcome of Board meeting held today, i.e 12 August 2026Board Meetinghigh impact
Cruxal's analysis: Suraksha Diagnostic Limited reported robust standalone financial results for the quarter…
Read the full analysis - We wish to inform that the 21st Annual General Meeting of the Company which was scheduled to be held on Wednesday, 02 September 2026, stands postponed to a future date due to certain unavoidable ....AGM/EGMlow impact
Cruxal's analysis: Suraksha Diagnostic Limited has formally notified the stock exchanges regarding the…
Read the full analysis - Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that there will be a Conference Call viz. ''Earnings Call'' ....Company Updatelow impact
Cruxal's analysis: Suraksha Diagnostic Limited has announced an earnings conference call scheduled for 13…
Read the full analysis - Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....Board Meetinglow impact
Cruxal's analysis: Suraksha Diagnostic Limited has announced a Board Meeting scheduled for Wednesday, August…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Suraksha Diagnostic Ltd
Cruxal reads every Suraksha Diagnostic Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.